Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: Implications for gene therapy

被引:65
作者
Amalfitano, A
Chamberiain, JS
机构
[1] UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,DEPT PEDIAT,DIV PEDIAT GENET,ANN ARBOR,MI 48109
关键词
adenovirus; gene therapy; 293; cells; polymerase; preterminal protein; packaging;
D O I
10.1038/sj.gt.3300378
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Current generation adenovirus (Ad) vectors are deleted for the E1 region of genes and require propagation in E1 expressing 293 cells. Expression of genes delivered by Ad vectors into immunocompetent hosts is generally transient since the current vectors are not completely replication defective. Viral proteins expressed by Ad vectors, in part, induce a rapid, T cell-mediated loss of transduced cells. Introduction of temperature-sensitive point mutations into new Ad vectors may be of limited usefulness in prolonging transduced gene expression in vivo. Isolation of new Ad vectors deleted for gene required for normal Ad growth may further prevent Ad protein expression. These new vectors will need to be grown in 293 cells capable of coexpressing other Ad genes. Unfortunately, many of the Ad genes are toxin when coexpressed in 293 cells. We describe the isolation of E1 expressing 293 cells which also express both the Ad polymerase and preterminal proteins, both of which are essential to normal Ad growth. The isolation of new Ad vectors deleted for the E1, polymerase and preterminal proteins are predicted to have many advantageous properties, including the prolongation of transduced foreign gene expression in vivo.
引用
收藏
页码:258 / 263
页数:6
相关论文
共 28 条
[11]   Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants [J].
Krougliak, V ;
Graham, FL .
HUMAN GENE THERAPY, 1995, 6 (12) :1575-1586
[12]   Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells [J].
KumarSingh, R ;
Chamberlain, JS .
HUMAN MOLECULAR GENETICS, 1996, 5 (07) :913-921
[13]   RESCUE, PROPAGATION, AND PARTIAL-PURIFICATION OF A HELPER VIRUS-DEPENDENT ADENOVIRUS VECTOR [J].
MITANI, K ;
GRAHAM, FL ;
CASKEY, CT ;
KOCHANEK, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (09) :3854-3858
[14]   MECHANISM OF ACTIVATION OF EARLY VIRAL TRANSCRIPTION BY THE ADENOVIRUS-E1A GENE-PRODUCT [J].
NEVINS, JR .
CELL, 1981, 26 (02) :213-220
[15]   REGULATION OF ADENOVIRUS-2 GENE-EXPRESSION AT THE LEVEL OF TRANSCRIPTIONAL TERMINATION AND RNA PROCESSING [J].
NEVINS, JR ;
WILSON, MC .
NATURE, 1981, 290 (5802) :113-118
[16]   ADENOVIRUS DNA-REPLICATION - THE FUNCTION OF THE COVALENTLY BOUND TERMINAL PROTEIN [J].
PRONK, R ;
STUIVER, MH ;
VANDERVLIET, PC .
CHROMOSOMA, 1992, 102 (01) :S39-S45
[17]  
SCHAACK J, 1989, CURR TOP MICROBIOL, V144, P185
[18]   ADENOVIRUS TYPE-5 PRECURSOR TERMINAL PROTEIN-EXPRESSING 293 AND HELA-CELL LINES [J].
SCHAACK, J ;
GUO, XL ;
HO, WYW ;
KARLOK, M ;
CHEN, CY ;
ORNELLES, D .
JOURNAL OF VIROLOGY, 1995, 69 (07) :4079-4085
[19]   ADENOVIRUS TERMINAL PROTEIN MEDIATES BOTH NUCLEAR MATRIX ASSOCIATION AND EFFICIENT TRANSCRIPTION OF ADENOVIRUS DNA [J].
SCHAACK, J ;
HO, WYW ;
FREIMUTH, P ;
SHENK, T .
GENES & DEVELOPMENT, 1990, 4 (07) :1197-1208
[20]  
THOMAS GP, 1980, CELL, V22, P523